<DOC>
	<DOCNO>NCT02335151</DOCNO>
	<brief_summary>Proportion circulate tumor cell ( CTC ) postoperative phase curative tumor removal pancreatic cancer determine correlate accordance anesthesia ( desflurane versus propofol )</brief_summary>
	<brief_title>CTC Pancreatic Adenocarcinoma</brief_title>
	<detailed_description>This prospective , randomize study conduct 36-month period investigate whether commonly use anesthetic ( volatile versus intravenous ) effect change occurrence CTC patient suffer primary pancreatic cancer undergo curative surgery . The specific research question change CTC count postoperative phase desflurane group ( intervention ) compare propofol one ( control ) . A secondary question change correlate tumor outcome .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Neoplastic Cells , Circulating</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Desflurane</mesh_term>
	<mesh_term>Isoflurane</mesh_term>
	<criteria>Age 18 85 ASA IIII ( American Society Anesthesiologists ) Resectable pancreatic adenocarcinoma Primary surgery No neoadjuvant therapy Written inform consent Metastatic disease Other primary surgery ( recurrence , reconstruction ) Preoperative chemotherapy Chronic opioid use Known hypersensitivity suspect allergy propofol , soya egg protein Known hypersensitivity volatile anaesthetic ( malignant hyperthermia ) Pregnancy Breast feed Enrolment clinical trial course trial , 30 day prior begin 30 day completion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Circulating Tumor Cells</keyword>
	<keyword>Anesthesia immunity</keyword>
	<keyword>Cell Search System</keyword>
</DOC>